Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head | 1 | 2011 | 248 | 0.330 |
Why?
|
| Neck | 1 | 2011 | 393 | 0.320 |
Why?
|
| Artifacts | 1 | 2011 | 536 | 0.300 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 585 | 0.290 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 19 | 0.260 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 151 | 0.240 |
Why?
|
| Organ Transplantation | 1 | 2005 | 203 | 0.210 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 2196 | 0.200 |
Why?
|
| Graft Survival | 1 | 2005 | 1081 | 0.200 |
Why?
|
| Graft Rejection | 1 | 2005 | 845 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 7784 | 0.130 |
Why?
|
| Radionuclide Imaging | 3 | 2008 | 655 | 0.090 |
Why?
|
| Indocyanine Green | 2 | 2008 | 125 | 0.090 |
Why?
|
| Biological Transport | 1 | 2011 | 627 | 0.090 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 469 | 0.080 |
Why?
|
| Lymphography | 1 | 2008 | 50 | 0.080 |
Why?
|
| Tretinoin | 1 | 2010 | 618 | 0.080 |
Why?
|
| Lymph Nodes | 2 | 2008 | 3078 | 0.070 |
Why?
|
| Lymphatic Vessels | 1 | 2008 | 138 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2005 | 106 | 0.060 |
Why?
|
| Thallium | 1 | 2005 | 12 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 1260 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2005 | 180 | 0.060 |
Why?
|
| Adenosine | 1 | 2005 | 296 | 0.050 |
Why?
|
| Mood Disorders | 1 | 2004 | 162 | 0.050 |
Why?
|
| Chest Pain | 1 | 2004 | 173 | 0.050 |
Why?
|
| Exercise Test | 1 | 2004 | 310 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 2518 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 883 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 1180 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 1301 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 2394 | 0.030 |
Why?
|
| Neoplasms | 2 | 2011 | 15919 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 6768 | 0.030 |
Why?
|
| Muscles | 1 | 2010 | 456 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 538 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 929 | 0.020 |
Why?
|
| Humans | 7 | 2011 | 270744 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1054 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 2008 | 51 | 0.020 |
Why?
|
| Gamma Cameras | 1 | 2008 | 39 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 206 | 0.020 |
Why?
|
| Sternum | 1 | 2008 | 96 | 0.020 |
Why?
|
| Male | 4 | 2011 | 128374 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 173 | 0.020 |
Why?
|
| Prevalence | 2 | 2005 | 3401 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 768 | 0.020 |
Why?
|
| Axilla | 1 | 2008 | 939 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 495 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 230 | 0.010 |
Why?
|
| Swine | 1 | 2008 | 1607 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 16205 | 0.010 |
Why?
|
| Texas | 2 | 2005 | 6447 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 4329 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 2119 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 2363 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 3089 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1689 | 0.010 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2008 | 1458 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 1406 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 1341 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3194 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 2496 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 2392 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 1825 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 4963 | 0.010 |
Why?
|
| Mice | 2 | 2010 | 35594 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 3448 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 5171 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 4328 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 14838 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 6192 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 62045 | 0.010 |
Why?
|
| Middle Aged | 3 | 2008 | 90334 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 10260 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 14012 | 0.010 |
Why?
|
| Female | 3 | 2008 | 148945 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 13414 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 17896 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 31006 | 0.000 |
Why?
|
| Prognosis | 1 | 2005 | 22480 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 73375 | 0.000 |
Why?
|
| Adult | 1 | 2008 | 81975 | 0.000 |
Why?
|